Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II-Induced Cardiac Hypertrophy

Circulation Research

Volumn 93, Issue 9, 2003, Pages 802-804

  Byrne, Jonathan A ^a   Grieve, David J ^a   Bendall, Jennifer K ^a   Li, Jian Mei ^a   Gove, Christopher ^a   Lambeth, J David ^b   Cave, Alison C ^a   Shah, Ajay M ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Angiotensin; Hypertrophy; NADPH oxidase; Pressure overload; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN; ANTIOXIDANT; ATRIAL NATRIURETIC FACTOR; GLYCOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOTENSIN II; ANIMALS; AORTA; BACTERIAL PROTEINS; BLOOD PRESSURE; CARDIOMEGALY; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HYPERTENSION; ISOENZYMES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MYOCARDIUM; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 0242298634     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000099504.30207.F5     Document Type: Article

References (11)

1. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18:655-673.
2. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, Namba M. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II. Circulation. 1998;98:794-799.
3. Pimentel DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, Baliga R, Wang J, Siwik DA, Singh K, Pagano P, Colucci WS, Sawyer DB. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res. 2001;89:453-460.
4. Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, Hirotani S, Matsumura Y, Hori M, Tada M, Otsu K. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol. 2002;39:907-912.
5. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
6. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
7. phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88:888-894.
8. Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension. 2002;40:477-484.
9. Wenzel S, Taimor G, Piper HM, Schluter KD. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-β expression in adult ventricular cardiomyocytes. FASEB J. 2001;15:2291-2293.
10. 1-adrenoceptor signaling in adult rat cardiac myocytes. Am J Physiol. 2002;282:C926-C934.
11. phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation. 2002;105:293-296.